PfATP4 screening - A pH-based 'fingerprint' screen to simultaneously identify inhibitors of multiple validated and potential antimalarial drug targets

Researchers

Grant status

Completed-Pending Reports

Grant start date

01/09/2019

Grant funding

  • 2019: $55,021 from Medicines for Malaria Venture
  • 2020: $61,086 from Medicines for Malaria Venture
  • 2021: $61,086 from Medicines for Malaria Venture

Updated:  02 December 2022 / Responsible Officer:  Director (Research Services Division) / Page Contact:  Researchers